Viewing Study NCT05429632


Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2026-05-19 @ 7:59 AM
Study NCT ID: NCT05429632
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2022-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Sponsor: Priothera SAS
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Acute Myeloid Leukemia View
Keywords: